Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.
Rajecki M, af Hällström T, Hakkarainen T, Nokisalmi P, Hautaniemi S, Nieminen AI, Tenhunen M, Rantanen V, Desmond RA, Chen DT, Guse K, Stenman UH, Gargini R, Kapanen M, Klefström J, Kanerva A, Pesonen S, Ahtiainen L, Hemminki A. Rajecki M, et al. Among authors: pesonen s. Int J Cancer. 2009 Nov 15;125(10):2441-9. doi: 10.1002/ijc.24608. Int J Cancer. 2009. PMID: 19672857
Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells.
Eriksson M, Guse K, Bauerschmitz G, Virkkunen P, Tarkkanen M, Tanner M, Hakkarainen T, Kanerva A, Desmond RA, Pesonen S, Hemminki A. Eriksson M, et al. Among authors: pesonen s. Mol Ther. 2007 Dec;15(12):2088-93. doi: 10.1038/sj.mt.6300300. Epub 2007 Sep 11. Mol Ther. 2007. PMID: 17848962 Free article.
Cancer, stem cells, and oncolytic viruses.
Ribacka C, Pesonen S, Hemminki A. Ribacka C, et al. Among authors: pesonen s. Ann Med. 2008;40(7):496-505. doi: 10.1080/07853890802021342. Ann Med. 2008. PMID: 18608120 Review.
Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
Bauerschmitz GJ, Ranki T, Kangasniemi L, Ribacka C, Eriksson M, Porten M, Herrmann I, Ristimäki A, Virkkunen P, Tarkkanen M, Hakkarainen T, Kanerva A, Rein D, Pesonen S, Hemminki A. Bauerschmitz GJ, et al. Among authors: pesonen s. Cancer Res. 2008 Jul 15;68(14):5533-9. doi: 10.1158/0008-5472.CAN-07-5288. Cancer Res. 2008. PMID: 18632604
Extended release of adenovirus from silica implants in vitro and in vivo.
Kangasniemi L, Koskinen M, Jokinen M, Toriseva M, Ala-Aho R, Kähäri VM, Jalonen H, Ylä-Herttuala S, Moilanen H, Stenman UH, Diaconu I, Kanerva A, Pesonen S, Hakkarainen T, Hemminki A. Kangasniemi L, et al. Among authors: pesonen s. Gene Ther. 2009 Jan;16(1):103-10. doi: 10.1038/gt.2008.142. Epub 2008 Aug 28. Gene Ther. 2009. PMID: 18754041
Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses.
Strauss R, Sova P, Liu Y, Li ZY, Tuve S, Pritchard D, Brinkkoetter P, Möller T, Wildner O, Pesonen S, Hemminki A, Urban N, Drescher C, Lieber A. Strauss R, et al. Among authors: pesonen s. Cancer Res. 2009 Jun 15;69(12):5115-25. doi: 10.1158/0008-5472.CAN-09-0645. Epub 2009 Jun 2. Cancer Res. 2009. PMID: 19491256 Free PMC article.
114 results